<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">HCV </span>
   <span class="font29">and </span>
   <span class="font29">the </span>
   <span class="font19">with </span>
   <span class="font18">hepatitis </span>
   <span class="font17">virus </span>
   <span class="font17">[]. </span>
   <span class="font17">RNA </span>
   <span class="font17">for </span>
   <span class="font15">inhibitors </span>
   <span class="font15">antiviral </span>
   <span class="font15">replication </span>
   <span class="font14">against </span>
   <span class="font14">activity </span>
   <span class="font14">which </span>
   <span class="font14">{background </span>
   <span class="font14">have </span>
   <span class="font13">are </span>
   <span class="font13">replicon </span>
   <span class="font13">helicase </span>
   <span class="font13">that </span>
   <span class="font13">margin </span>
   <span class="font13">protease </span>
   <span class="font13">{border-style </span>
   <span class="font12">been </span>
   <span class="font12">polymerase </span>
   <span class="font12">potent </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">inhibitor </span>
   <span class="font12">novel </span>
   <span class="font12">viral </span>
   <span class="font12">combination </span>
   <span class="font12">compounds </span>
   <span class="font12">binding </span>
   <span class="font12">cell </span>
   <span class="font12">has </span>
   <span class="font12">resistance </span>
   <span class="font12">was </span>
   <span class="font12">The </span>
   <span class="font12">derivatives </span>
   <span class="font12">effects </span>
   <span class="font12">entry </span>
   <span class="font12">were </span>
   <span class="font11">Agents </span>
   <span class="font11">clinical </span>
   <span class="font11">from </span>
   <span class="font11">may </span>
   <span class="font11">NSB </span>
   <span class="font11">therapy </span>
   <span class="font11">various </span>
   <span class="font11">patients </span>
   <span class="font11">proteins </span>
   <span class="font11">replicons </span>
   <span class="font11">Chemother./AAC.- </span>
   <span class="font11">cellular </span>
   <span class="font11">different </span>
   <span class="font11">drugs </span>
   <span class="font11">genotype </span>
   <span class="font11">inhibition </span>
   <span class="font11">other </span>
   <span class="font11">protein </span>
   <span class="font11">Chem </span>
   <span class="font11">Med </span>
   <span class="font11">px; </span>
   <span class="font11">ribavirin </span>
   <span class="font11">standard </span>
   <span class="font11">treatment </span>
   <span class="font11">while </span>
   <span class="font11">{font-family </span>
   <span class="font11">RNA-dependent </span>
   <span class="font11">anti-HCV </span>
   <span class="font11">chronic </span>
   <span class="font11">drug </span>
   <span class="font11">font-size </span>
   <span class="font11">found </span>
   <span class="font11">infected </span>
   <span class="font11">infection </span>
   <span class="font11">replication. </span>
   <span class="font11">such </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">Inhibitors </span>
   <span class="font10">NS/A </span>
   <span class="font10">SCY- </span>
   <span class="font10">but </span>
   <span class="font10">combinational </span>
   <span class="font10">double; </span>
   <span class="font10">especially </span>
   <span class="font10">exhibit </span>
   <span class="font10">genome </span>
   <span class="font10">in-vitro </span>
   <span class="font10">into </span>
   <span class="font10">polyprotein </span>
   <span class="font10">resistant </span>
   <span class="font10">serine </span>
   <span class="font10">shown </span>
   <span class="font10">side </span>
   <span class="font10">study </span>
   <span class="font10">synthesized </span>
   <span class="font10">targeting </span>
   <span class="font10">than </span>
   <span class="font10">these </span>
   <span class="font10">ACH- </span>
   <span class="font10">AG- </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Debio </span>
   <span class="font10">HCV. </span>
   <span class="font10">ITMN- </span>
   <span class="font10">NSA </span>
   <span class="font10">TMC </span>
   <span class="font10">This </span>
   <span class="font10">Various </span>
   <span class="font10">activity, </span>
   <span class="font10">also </span>
   <span class="font10">being </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">changes </span>
   <span class="font10">containing </span>
   <span class="font10">due </span>
   <span class="font10">host </span>
   <span class="font10">human </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibitors. </span>
   <span class="font10">involved </span>
   <span class="font10">low </span>
   <span class="font10">most </span>
   <span class="font10">regime </span>
   <span class="font10">series </span>
   <span class="font10">site </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">studies </span>
   <span class="font10">subgenomic </span>
   <span class="font10">synergistic </span>
   <span class="font10">system </span>
   <span class="font10">target </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Chemother </span>
   <span class="font10">CsA </span>
   <span class="font10">Figure </span>
   <span class="font10">HCV- </span>
   <span class="font10">Helicase </span>
   <span class="font10">IFN </span>
   <span class="font10">RdRp </span>
   <span class="font10">STAT-C </span>
   <span class="font10">[,]. </span>
   <span class="font10">[], </span>
   <span class="font10">acid </span>
   <span class="font10">activities </span>
   <span class="font10">additive </span>
   <span class="font10">along </span>
   <span class="font10">bold </span>
   <span class="font10">box </span>
   <span class="font10">can </span>
   <span class="font10">compound </span>
   <span class="font10">courier; </span>
   <span class="font10">cyclophilin </span>
   <span class="font10">development </span>
   <span class="font10">em; </span>
   <span class="font10">first </span>
   <span class="font10">mechanism </span>
   <span class="font10">mutations </span>
   <span class="font10">new </span>
   <span class="font10">potential </span>
   <span class="font10">proteins. </span>
   <span class="font10">prove </span>
   <span class="font10">pt;} </span>
   <span class="font10">rate </span>
   <span class="font10">recognized </span>
   <span class="font10">related </span>
   <span class="font10">response </span>
   <span class="font10">showing </span>
   <span class="font10">structural </span>
   <span class="font10">targets </span>
   <span class="font10">their </span>
   <span class="font10">there </span>
   <span class="font10">this </span>
   <span class="font10">unwinding </span>
   <span class="font10">used </span>
   <span class="font10">using </span>
  </p>
 </body>
</html>
